FSMEX vs. FNILX

In the year-to-date period, FSMEX achieves a -3.41% return, which is significantly lower than FNILX's 1.82% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

FSMEX has a 0.68% expense ratio, which is higher than FNILX's 0.00% expense ratio.

This table presents a comparison of risk-adjusted performance metrics for Fidelity Select Medical Technology and Devices Portfolio (FSMEX) and Fidelity ZERO Large Cap Index Fund (FNILX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current FSMEX Sharpe Ratio is -0.36, which is lower than the FNILX Sharpe Ratio of 0.73. The chart below compares the historical Sharpe Ratios of FSMEX and FNILX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

FSMEX has not paid dividends to shareholders, while FNILX's dividend yield for the trailing twelve months is around 1.07%.

The maximum FSMEX drawdown since its inception was -43.45%, which is greater than FNILX's maximum drawdown of -33.75%. Use the drawdown chart below to compare losses from any high point for FSMEX and FNILX. For additional features, visit the drawdowns tool.

Fidelity Select Medical Technology and Devices Portfolio (FSMEX) and Fidelity ZERO Large Cap Index Fund (FNILX) have volatilities of 5.51% and 5.47%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.